These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 29853256)

  • 1. Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline.
    Vaquero J; Zurita M; Rico MA; Aguayo C; Bonilla C; Marin E; Tapiador N; Sevilla M; Vazquez D; Carballido J; Fernandez C; Rodriguez-Boto G; Ovejero M;
    Cytotherapy; 2018 Jun; 20(6):806-819. PubMed ID: 29853256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injury.
    Vaquero J; Zurita M; Rico MA; Bonilla C; Aguayo C; Fernández C; Tapiador N; Sevilla M; Morejón C; Montilla J; Martínez F; Marín E; Bustamante S; Vázquez D; Carballido J; Rodríguez A; Martínez P; García C; Ovejero M; Fernández MV;
    Cytotherapy; 2017 Mar; 19(3):349-359. PubMed ID: 28089079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell therapy with autologous mesenchymal stromal cells in post-traumatic syringomyelia.
    Vaquero J; Zurita M; Rico MA; Aguayo C; Fernandez C; Rodriguez-Boto G; Marin E; Tapiador N; Sevilla M; Carballido J; Vazquez D; Garcia-Olmo D; Guadalajara H; Leon M; Valverde I;
    Cytotherapy; 2018 Jun; 20(6):796-805. PubMed ID: 29784434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study.
    Albu S; Kumru H; Coll R; Vives J; Vallés M; Benito-Penalva J; Rodríguez L; Codinach M; Hernández J; Navarro X; Vidal J
    Cytotherapy; 2021 Feb; 23(2):146-156. PubMed ID: 32981857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study.
    Yang Y; Pang M; Du C; Liu ZY; Chen ZH; Wang NX; Zhang LM; Chen YY; Mo J; Dong JW; Xie PG; Wang QY; Liu B; Rong LM
    Cytotherapy; 2021 Jan; 23(1):57-64. PubMed ID: 33218835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: A human trial.
    Hur JW; Cho TH; Park DH; Lee JB; Park JY; Chung YG
    J Spinal Cord Med; 2016 Nov; 39(6):655-664. PubMed ID: 26208177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury.
    Mendonça MV; Larocca TF; de Freitas Souza BS; Villarreal CF; Silva LF; Matos AC; Novaes MA; Bahia CM; de Oliveira Melo Martinez AC; Kaneto CM; Furtado SB; Sampaio GP; Soares MB; dos Santos RR
    Stem Cell Res Ther; 2014 Nov; 5(6):126. PubMed ID: 25406723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An approach to personalized cell therapy in chronic complete paraplegia: The Puerta de Hierro phase I/II clinical trial.
    Vaquero J; Zurita M; Rico MA; Bonilla C; Aguayo C; Montilla J; Bustamante S; Carballido J; Marin E; Martinez F; Parajon A; Fernandez C; Reina L;
    Cytotherapy; 2016 Aug; 18(8):1025-1036. PubMed ID: 27311799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous mesenchymal stromal cell transplantation for spinal cord injury: A Phase I pilot study.
    Satti HS; Waheed A; Ahmed P; Ahmed K; Akram Z; Aziz T; Satti TM; Shahbaz N; Khan MA; Malik SA
    Cytotherapy; 2016 Apr; 18(4):518-22. PubMed ID: 26971680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and potential efficacy of expanded mesenchymal stromal cells of bone marrow and umbilical cord origins in patients with chronic spinal cord injuries: a phase I/II study.
    Awidi A; Al Shudifat A; El Adwan N; Alqudah M; Jamali F; Nazer F; Sroji H; Ahmad H; Al-Quzaa N; Jafar H
    Cytotherapy; 2024 Aug; 26(8):825-831. PubMed ID: 38703153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image-guided percutaneous intralesional administration of mesenchymal stromal cells in subjects with chronic complete spinal cord injury: a pilot study.
    Larocca TF; Macêdo CT; Souza BSF; Andrade-Souza YM; Villarreal CF; Matos AC; Silva DN; da Silva KN; de Souza CLEM; Paixão DDS; Bezerra MDR; Alves RL; Soares MBP; Dos Santos RR
    Cytotherapy; 2017 Oct; 19(10):1189-1196. PubMed ID: 28760352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes.
    Oraee-Yazdani S; Akhlaghpasand M; Golmohammadi M; Hafizi M; Zomorrod MS; Kabir NM; Oraee-Yazdani M; Ashrafi F; Zali A; Soleimani M
    Stem Cell Res Ther; 2021 Aug; 12(1):445. PubMed ID: 34372939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal administration of autologous bone marrow stromal cells improves neuropathic pain in patients with spinal cord injury.
    Vaquero J; Zurita M; Rico MA; Aguayo C; Fernández C; Gutiérrez R; Rodríguez-Boto G; Saab A; Hassan R; Ortega C
    Neurosci Lett; 2018 Mar; 670():14-18. PubMed ID: 29366770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-bladder wall transplantation of bone marrow mesenchymal stem cells improved urinary bladder dysfunction following spinal cord injury.
    Salehi-Pourmehr H; Rahbarghazi R; Mahmoudi J; Roshangar L; Chapple CR; Hajebrahimi S; Abolhasanpour N; Azghani MR
    Life Sci; 2019 Mar; 221():20-28. PubMed ID: 30735734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells.
    Liu J; Han D; Wang Z; Xue M; Zhu L; Yan H; Zheng X; Guo Z; Wang H
    Cytotherapy; 2013 Feb; 15(2):185-91. PubMed ID: 23321330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome.
    Oraee-Yazdani S; Hafizi M; Atashi A; Ashrafi F; Seddighi AS; Hashemi SM; Seddighi A; Soleimani M; Zali A
    Spinal Cord; 2016 Feb; 54(2):102-9. PubMed ID: 26526896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial.
    Bydon M; Qu W; Moinuddin FM; Hunt CL; Garlanger KL; Reeves RK; Windebank AJ; Zhao KD; Jarrah R; Trammell BC; El Sammak S; Michalopoulos GD; Katsos K; Graepel SP; Seidel-Miller KL; Beck LA; Laughlin RS; Dietz AB
    Nat Commun; 2024 Apr; 15(1):2201. PubMed ID: 38561341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series.
    Honmou O; Yamashita T; Morita T; Oshigiri T; Hirota R; Iyama S; Kato J; Sasaki Y; Ishiai S; Ito YM; Namioka A; Namioka T; Nakazaki M; Kataoka-Sasaki Y; Onodera R; Oka S; Sasaki M; Waxman SG; Kocsis JD
    Clin Neurol Neurosurg; 2021 Apr; 203():106565. PubMed ID: 33667953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.
    Pal R; Venkataramana NK; Bansal A; Balaraju S; Jan M; Chandra R; Dixit A; Rauthan A; Murgod U; Totey S
    Cytotherapy; 2009; 11(7):897-911. PubMed ID: 19903102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model.
    Yousefifard M; Nasirinezhad F; Shardi Manaheji H; Janzadeh A; Hosseini M; Keshavarz M
    Stem Cell Res Ther; 2016 Mar; 7():36. PubMed ID: 26957122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.